S with progranulin and CTRP3 levels as

S with progranulin and CTRP3 levels as 1516647 dependent variables was performed to identify the risk factors that determine serum progranulin and CTRP3 concentrations in the study subjects. The second multiple linear stepwise regression analysis was performed to determine the risk factors for the CIMT values in subjects with or without metabolic syndrome. The significance level for entry and for stay in the model was chosen to be 0.15 (the default values in SAS statistical software package). All statistical results were based on two-sided tests. Data were analyzed using SAS 9.2 (SAS Institute, Cary, NC). We regarded a P-value ,0.05 as statistically meaningful.group. Importantly, circulating progranulin concentrations in the metabolic syndrome group were greater than those in the control group, and almost reached a significant level (199.55 [179.33, 215.53] vs. 185.10 [160.30, 204.90], P = 0.051), whereas there was no significant difference in serum CTRP3 levels.Correlation of Circulating Progranulin and CTRP3 Concentrations with Cardiometabolic Risk FactorsSerum progranulin levels had significant positive correlations with serum hsCRP and IL-6 levels (r = 0.304, P = 0.001 and r = 0.300, P = 0.001, respectively), but had no significant correlations with 56-59-7 chemical information various metabolic parameters, including BMI, waist circumference, glucose tolerance, blood pressure, and lipid profiles (Table 2). On the other hand, circulating CTRP3 levels were significantly negatively correlated with waist circumference, diastolic blood pressure, total cholesterol, triglyceride, and fasting glucose levels, and positively correlated with age, eGFR, and serum adiponectin levels. However, serum CTRP3 concentrations had no significant correlation with serum hsCRP or IL-6 levels. Interestingly, the number of metabolic syndrome components had a significant positive relationship with circulating progranulin levels (r = 0.227, P = 0.010) and a negative correlation with CTRP3 levels (r = 20.175, P = 0.050). Moreover, serum progranulin levels increased significantly according to the number of metabolic syndrome components (P for linear trend ,0.01,Results Baseline Characteristic of the Study SubjectsThe clinical and biochemical characteristics of the study subjects are presented in Table 1. The metabolic syndrome group showed a significantly higher mean BMI, waist circumference, blood pressure, triglyceride, total cholesterol, fasting glucose, HOMA-IR, hsCRP, and CIMT values compared to the control group. HDL-cholesterol and adiponectin levels in the metabolic syndrome group were significantly lower than in the controlProgranulin and CTRP3 in Metabolic SyndromeFigure 1), whereas CTRP3 serum concentration decreased significantly (P for linear trend = 0.04, Figure 1). In multiple stepwise linear regression analysis, IL-6 (P = 0.01) and triglyceride (P,0.001) levels were significant determining factors for serum progranulin levels (R2 = 0.251), whereas sex (P,0.001), triglyceride levels (P,0.001) and LDL-cholesterol levels (P = 0.02) were significant Deslorelin decisive factors for circulating CTRP3 concentrations (R2 = 0.321) (Table S1).Table 2. Spearman Correlation of Serum Progranulin and CTRP3 with Various Metabolic Parameters.CTRPProgranulinrSex Age 0.476 0.240 20.129 20.214 20.076 20.207 20.126 20.138 20.245 0.093 20.338 20.135 20.198 20.108 0.392 0.125 20.050 0.P,0.001 0.007 0.149 0.016 0.397 0.020 0.159 0.123 0.006 0.302 ,0.001 0.131 0.026 0.321 ,0.001 0.162 0.574 0.r0.127 0.016 0.126 0.098.S with progranulin and CTRP3 levels as 1516647 dependent variables was performed to identify the risk factors that determine serum progranulin and CTRP3 concentrations in the study subjects. The second multiple linear stepwise regression analysis was performed to determine the risk factors for the CIMT values in subjects with or without metabolic syndrome. The significance level for entry and for stay in the model was chosen to be 0.15 (the default values in SAS statistical software package). All statistical results were based on two-sided tests. Data were analyzed using SAS 9.2 (SAS Institute, Cary, NC). We regarded a P-value ,0.05 as statistically meaningful.group. Importantly, circulating progranulin concentrations in the metabolic syndrome group were greater than those in the control group, and almost reached a significant level (199.55 [179.33, 215.53] vs. 185.10 [160.30, 204.90], P = 0.051), whereas there was no significant difference in serum CTRP3 levels.Correlation of Circulating Progranulin and CTRP3 Concentrations with Cardiometabolic Risk FactorsSerum progranulin levels had significant positive correlations with serum hsCRP and IL-6 levels (r = 0.304, P = 0.001 and r = 0.300, P = 0.001, respectively), but had no significant correlations with various metabolic parameters, including BMI, waist circumference, glucose tolerance, blood pressure, and lipid profiles (Table 2). On the other hand, circulating CTRP3 levels were significantly negatively correlated with waist circumference, diastolic blood pressure, total cholesterol, triglyceride, and fasting glucose levels, and positively correlated with age, eGFR, and serum adiponectin levels. However, serum CTRP3 concentrations had no significant correlation with serum hsCRP or IL-6 levels. Interestingly, the number of metabolic syndrome components had a significant positive relationship with circulating progranulin levels (r = 0.227, P = 0.010) and a negative correlation with CTRP3 levels (r = 20.175, P = 0.050). Moreover, serum progranulin levels increased significantly according to the number of metabolic syndrome components (P for linear trend ,0.01,Results Baseline Characteristic of the Study SubjectsThe clinical and biochemical characteristics of the study subjects are presented in Table 1. The metabolic syndrome group showed a significantly higher mean BMI, waist circumference, blood pressure, triglyceride, total cholesterol, fasting glucose, HOMA-IR, hsCRP, and CIMT values compared to the control group. HDL-cholesterol and adiponectin levels in the metabolic syndrome group were significantly lower than in the controlProgranulin and CTRP3 in Metabolic SyndromeFigure 1), whereas CTRP3 serum concentration decreased significantly (P for linear trend = 0.04, Figure 1). In multiple stepwise linear regression analysis, IL-6 (P = 0.01) and triglyceride (P,0.001) levels were significant determining factors for serum progranulin levels (R2 = 0.251), whereas sex (P,0.001), triglyceride levels (P,0.001) and LDL-cholesterol levels (P = 0.02) were significant decisive factors for circulating CTRP3 concentrations (R2 = 0.321) (Table S1).Table 2. Spearman Correlation of Serum Progranulin and CTRP3 with Various Metabolic Parameters.CTRPProgranulinrSex Age 0.476 0.240 20.129 20.214 20.076 20.207 20.126 20.138 20.245 0.093 20.338 20.135 20.198 20.108 0.392 0.125 20.050 0.P,0.001 0.007 0.149 0.016 0.397 0.020 0.159 0.123 0.006 0.302 ,0.001 0.131 0.026 0.321 ,0.001 0.162 0.574 0.r0.127 0.016 0.126 0.098.